Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

You searched for subject:(Drug lifecycle management). One record found.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters


University of Queensland

1. Almutairi, Ibrahim. Patent Portfolio Constructionism for Biopharmaceuticals Lifecycle Management.

Degree: School of Chemistry and Molecular Biosciences, 2019, University of Queensland

Biopharmaceutical inventions challenge the patent system’s ability to provide sufficient market exclusivity for new and emergent technologies and create a competitive advantage. Recently, the theory of ‘the patent portfolio’ has emerged to explain modern views of the value of exclusivity. This thesis aims to address the increasing complexity and nature of the ‘private value’ of patent portfolios and the related companies’ patenting strategies in the biopharmaceutical industry. The inconsistent understanding of, and the underlying linkage between, the ‘private value’ of patent portfolios and patenting strategies often results in reduced efficiency in drug lifecycle management. In an attempt to characterize companies’ patenting strategies, the logic behind the influence of patent portfolio attributes in the process of ‘private value’ creation has been examined. This thesis attempts to develop a novel conceptual model of ‘private value’ and advance the understanding of patent portfolios in therapeutic biologics. The model of ‘private value’ integrates a conceptual framework of the portfolio attributes of Scale, Technology Diversity, Total Citations and Age. The conceptual model was empirically investigated using data sources of patent portfolios for 116 FDA approved therapeutic biologics. Portfolio ‘private value’ attribute variances were employed to identify the incremental ‘private value’ constructs of patent portfolios using Principal Component Analysis. In addition, given the diversity of patenting strategies, an investigation of how patenting behaviours across biopharmaceutical companies influence the ‘private value’ of patent portfolios in the drug lifecycle management process was conducted.The findings in this thesis contribute to the understanding of the ‘private value’ in biopharmaceutical lifecycle management (LCM) in a number of ways. The analysis shows that the ‘private value’ of patent portfolios is most closely related to the technical scope constructs of ‘Uncertainty’ and ‘Substitution’. The results also indicate that the attributes that contribute most to ‘private value’ are Scale, Total Citations, and Age withScale being the most important. On the basis of my research, I suggest the consideration of alternative attributes for patent portfolio theory, i.e. the ‘Technology Strength’ and ‘Lifetime’. Moreover, the synergy of both proposed attributes is as important as the factors themselves.Three patent clusters for patenting patterns were identified. The cluster taxonomy shows the impact of portfolio characteristics on the selected patenting strategies. The observed patenting strategies confirm the dominance of offensive strategies to increase the lifecycle of therapeutic biologics. Offensive blockage strategies are invariably connected with the creation of early ‘Uncertainty’ and later ‘Substitution’ constructs of ‘private value’. The findings suggest that the most successful configuration of patent portfolios is characterised by targeted patenting strategies that are in alignment with the desired…

Subjects/Keywords: Biopharmaceuticals patenting; Therapeutic biologics patenting; Patent portfolios; Portfolio private value; Patenting strategy; Patent analysis; Patent clustering; Drug lifecycle management; 1004 Medical Biotechnology; 1503 Business and Management; 1801 Law

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Almutairi, I. (2019). Patent Portfolio Constructionism for Biopharmaceuticals Lifecycle Management. (Thesis). University of Queensland. Retrieved from http://espace.library.uq.edu.au/view/UQ:0

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Almutairi, Ibrahim. “Patent Portfolio Constructionism for Biopharmaceuticals Lifecycle Management.” 2019. Thesis, University of Queensland. Accessed August 22, 2019. http://espace.library.uq.edu.au/view/UQ:0.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Almutairi, Ibrahim. “Patent Portfolio Constructionism for Biopharmaceuticals Lifecycle Management.” 2019. Web. 22 Aug 2019.

Vancouver:

Almutairi I. Patent Portfolio Constructionism for Biopharmaceuticals Lifecycle Management. [Internet] [Thesis]. University of Queensland; 2019. [cited 2019 Aug 22]. Available from: http://espace.library.uq.edu.au/view/UQ:0.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Almutairi I. Patent Portfolio Constructionism for Biopharmaceuticals Lifecycle Management. [Thesis]. University of Queensland; 2019. Available from: http://espace.library.uq.edu.au/view/UQ:0

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

.